Back
4D Molecular Therapeutics Stock Price Chart
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
26
FDMT
4D Molecular Therapeutics
Last Price:
8.26
Seasonality Move:
106.87%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing slight selling pressure.
4D Molecular Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.21 | Sell |
| 20-day SMA: | 8.58 | Sell |
| 50-day SMA: | 11.72 | Sell |
| 200-day SMA: | 20.9 | Sell |
| 8-day EMA: | 8.25 | Sell |
| 20-day EMA: | 8.93 | Sell |
| 50-day EMA: | 11.31 | Sell |
| 200-day EMA: | 17.19 | Sell |
4D Molecular Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.98 | Sell |
| Relative Strength Index (14 RSI): | 32.08 | Sell |
| Chaikin Money Flow: | -60926 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.13 - 9.75) | Sell |
| Bollinger Bands (100): | (10.3 - 20.64) | Sell |
4D Molecular Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for 4D Molecular Therapeutics Stock
Is 4D Molecular Therapeutics Stock a Buy?
- 4D Molecular Therapeutics share price is 8.18 while FDMT 8-day simple moving average is 8.21, which is a Sell signal.
- The stock price of FDMT is 8.18 while 4D Molecular Therapeutics 20-day SMA is 8.58, which makes it a Sell.
- 4D Molecular Therapeutics 50-day simple moving average is 11.72 while FDMT share price is 8.18, making it a Sell technically.
- FDMT stock price is 8.18 and 4D Molecular Therapeutics 200-day simple moving average is 20.90, creating a Sell signal.
FDMT Technical Analysis vs Fundamental Analysis
Sell
26
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics a Buy or a Sell?
-
4D Molecular Therapeutics stock is rated a Sell
The current 4D Molecular Therapeutics [FDMT] share price is $8.18. The Score for FDMT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
4D Molecular Therapeutics Stock Info
Market Cap:
424.85M
Price in USD:
8.18
Share Volume:
504.03K
4D Molecular Therapeutics 52-Week Range
52-Week High:
36.25
52-Week Low:
7.90
Sell
26
4D Molecular Therapeutics (FDMT)
is a Sell
4D Molecular Therapeutics Share Price Forecast
-
What is the 4D Molecular Therapeutics stock price today?
The 4D Molecular Therapeutics stock price is 8.18 USD today. -
Will FDMT stock go up or go down?
4D Molecular Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is 4D Molecular Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, 4D Molecular Therapeutics is overvalued.
Is 4D Molecular Therapeutics Stock a Buy?
- 4D Molecular Therapeutics share price is 8.18 while FDMT 8-day exponential moving average is 8.25, which is a Sell signal.
- The stock price of FDMT is 8.18 while 4D Molecular Therapeutics 20-day EMA is 8.93, which makes it a Sell.
- 4D Molecular Therapeutics 50-day exponential moving average is 11.31 while FDMT share price is 8.18, making it a Sell technically.
- FDMT stock price is 8.18 and 4D Molecular Therapeutics 200-day simple moving average is 17.19, creating a Sell signal.
Fundamental Analysis of 4D Molecular Therapeutics
Is 4D Molecular Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.49 per share.
Technical Analysis of 4D Molecular Therapeutics
Should I short 4D Molecular Therapeutics stock?
- FDMT Moving Average Covergence Divergence (MACD) indicator is -0.98, suggesting 4D Molecular Therapeutics is a Sell
- 4D Molecular Therapeutics Relative Strength Index (RSI) is 32.08, which suggest 4D Molecular Therapeutics is oversold
- The Bollinger Bands (25) for 4D Molecular Therapeutics is (8.13 - 9.75), which suggest 4D Molecular Therapeutics is a Sell
- The Bollinger Bands (100) for 4D Molecular Therapeutics is (10.3 - 20.64), which suggest 4D Molecular Therapeutics is a Sell
* 4D Molecular Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.